on Reducing Common Bacteria and Fungi on Surfaces* in 24-hour Testing
Effects of ActivePure (RCI) Technology
Testing by Kansas State University. Field results may vary based on environmental conditions.
Scientific tests have demonstrated the technology in activTek air purifiers can substantially reduce microbial populations on surfaces-including but not limited to Escherichia coli, Listeria monocytogenes, Streptococcus spp., Pseudomonas aeruginosa, Bacillus spp., Staphylococcus aureus, Candida albicans, and S. chartarum. Presently activTek does not make a similar claim with respect to airborne microbials. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Summary of Test Results
Biological Reductions using ActivePure (Ozone at .02 ppm)
- Staphylococcus aureus: 98.5% reduction
- E-coli: 98.1% reduction
- Bacillus spp.: 99.38% reduction
- MRSA: 99.8% reduction
- Streptococcus spp.: 96.4% reduction
- Pseudomonas spp.: 99.0% reduction
- Listeria: 99.75% reduction
- Candida albicans: 99.92% reduction
- Stachybotrys: 99.93% reduction
Percent of Microbe Reduction
Average of two 24-hour tests
Comparing the Effects of ActivePure (RCI) Technology & Ozone Technology
on Reducing Common Bacteria & Fungi on Surfaces in 24-hour Testing
We have commissioned testing of our ActivePure®Technology. The studies* refer to the ActivePure®Technology by its generic name, RCI. The studies’ results are being provided solely for informational purposes. The studies’ results have not been reviewed by the FDA, EPA or any other governmental agency. Our products are not medical devices and are not intended to diagnose, treat, or cure any disease.